C&EN White Paper
Characterizing Subvisible Particles in Protein-Based Drugs
Aligning with New USP Guidance using Flow Imaging Microscopy

Brought to you by Yokogawa Fluid Imaging Technologies
Overview

A recent USP "Stimuli to the Revision Process" article highlights the need for orthogonal methods like Flow Imaging Microscopy (FIM) to distinguish silicone oil droplets (SiOPs) from protein aggregates, as traditional light obscuration often fails to detect these low-contrast particles. Using FlowCam technology, this study demonstrates how high-resolution imaging and quantitative morphological data allow for the precise classification required to meet evolving regulatory standards.

By leveraging FIM, manufacturers can differentiate round SiOPs from irregular proteinaceous aggregates, even at the submicron level, where detailed surface textures reveal particle origins. This automated, high-throughput approach provides the comprehensive characterization necessary to ensure the safety and efficacy of modern biopharmaceuticals.

Key Objectives:
  • The Limitations of Light Obscuration (LO): Understand why LO struggles to detect low-contrast protein aggregates and SiOPs.
  • How to Apply USP Guidance: Align with the new USP Stimuli article by using FIM as an important orthogonal method.
  • The Best FIM Settings to Differentiate Morphologies: Use FlowCam shape properties to distinguish round SiOPs from irregular protein aggregates.
  • Tools to Analyze Submicron Particles: Use FlowCam Nano to reveal surface textures and features in submicron particles that are invisible at lower magnifications.

Brought to you by:
Yokogawa Fluid Imaging Technologies logo
This content was created by Yokogawa Fluid Imaging Technologies, without editorial input from the C&EN Media Group. For more information on C&EN's custom products, visit our C&EN Media Kit.
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2026 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy